These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Salmeterol xinafoate vs albuterol in asthma: was race a factor? Olopade CO JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862 [No Abstract] [Full Text] [Related]
7. Loss of bronchoprotection with salmeterol. D'Urzo AD Chest; 1996 Jul; 110(1):306. PubMed ID: 8681659 [No Abstract] [Full Text] [Related]
8. Asthma mortality and beta-agonists. Skorodin MS Chest; 1995 Dec; 108(6):1768. PubMed ID: 7497807 [No Abstract] [Full Text] [Related]
9. Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained. Sears MR; Taylor DR BMJ; 1993 Jun; 306(6892):1610-1. PubMed ID: 8101115 [No Abstract] [Full Text] [Related]
16. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
17. Beta2 déjà vu. O'Byrne PM; Adelroth E Chest; 2006 Jan; 129(1):3-5. PubMed ID: 16424402 [No Abstract] [Full Text] [Related]
18. Salmeterol does not cause tolerance during long-term asthma therapy. Arledge TE; Liddle R; Stahl E; Rossing TH J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1116-9. PubMed ID: 8977514 [No Abstract] [Full Text] [Related]
19. Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma? Devoy MA; Fuller RW; Palmer JB Chest; 1995 Apr; 107(4):1116-24. PubMed ID: 7705125 [No Abstract] [Full Text] [Related]
20. Long acting beta 2 agonists and the risk of life threatening asthma. Ernst P Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513 [No Abstract] [Full Text] [Related] [Next] [New Search]